Barclays raises Manulife target to CAD 61 for Manulife stock

Published on 10/13/2026 at 12:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 core EPS grew 16.00 percent year over year. Manulife stock was EUR 38.13 on October 13, 2026, with results due November 4, 2026.

Barclays raised its Manulife price target from CAD 59.00 to CAD 61.00 while retaining an Equal Weight rating.
Manulife reported 16.00 percent year-over-year growth in core earnings per share in the second quarter of 2026.
The stock was trading at EUR 38.13 at Lang & Schwarz on October 13, 2026, at 12:18 p.m. CEST.
Manulife's next earnings date is November 4, 2026, according to a current earnings calendar entry.

MFC, CA56501R1064, Illustration mit AI erstellt.

Manulife (ISIN CA56501R1064) was trading at EUR 38.13 at Lang & Schwarz on October 13, 2026, at 12:18 p.m. CEST. On October 7, 2026, Barclays analyst Alex Scott raised the price target from CAD 59.00 to CAD 61.00 and retained an Equal Weight rating, as Markets Insider reported.

Three dated developments

On August 5, 2026, Manulife announced a long-term care reinsurance transaction covering USD 3.20 billion of reserves, according to The Fly. On August 6, 2026, the company reported second-quarter core earnings per share growth of 16.00 percent year over year, with net income of CAD 2.10 billion, according to Benzinga. On October 7, Barclays updated its target to CAD 61.00.

What does the reinsurance deal mean

The transaction transfers biometric risk on a long-term care block while Manulife retains the related asset portfolio. Management said the deal reduces long-term care morbidity risk by 24.00 percent after earlier transactions and carries a first-year core earnings impact of CAD 30.00 million.

The second-quarter figures show why the target change is selective rather than a broad rating upgrade. APE sales rose 21.00 percent year over year, new business CSM increased 16.00 percent, and the LICAT capital ratio stood at 136.00 percent. At the same time, Manulife reported unfavorable insurance experience in Canada, making claims performance a counterweight to growth in Asia and Global WAM.

Leadership and results dates

Sinéad O'Connor became Manulife's chief actuary on October 12, 2026, joining the Executive Leadership Team, according to StockTitan. The next earnings date is November 4, 2026, while the latest reported period ended June 30, 2026, according to Simply Wall St.

Stock price and investor context

Manulife's market capitalization was listed at CAD 100.5 billion in the latest available market overview, while its primary listing is the Toronto Stock Exchange under ticker MFC. The EUR 38.13 Lang & Schwarz quote gives German investors a live euro reference as Barclays sets its CAD 61.00 target against the Canadian listing.

The further course of trading is shown by the continuously updated real-time quote of Manulife stock.